Cubist Systematic Strategies, LLC Innoviva, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$14.56 - $16.78 $1.56 Million - $1.79 Million
106,849 New
106,849 $1.63 Million
Q3 2023

Nov 14, 2023
BUY
$12.37 - $13.89 $1.58 Million - $1.77 Million
127,666 Added 229.88%
183,203 $2.38 Million
Q2 2023

Aug 14, 2023
BUY
$11.39 - $13.72 $632,566 - $761,967
55,537 New
55,537 $706,000
Q4 2022

Feb 14, 2023
SELL
$11.8 - $13.78 $806,648 - $942,000
-68,360 Reduced 45.81%
80,852 $1.07 Million
Q3 2022

Nov 14, 2022
BUY
$11.61 - $15.22 $227,439 - $298,159
19,590 Added 15.11%
149,212 $1.73 Million
Q2 2022

Aug 15, 2022
SELL
$14.32 - $19.88 $1.5 Million - $2.08 Million
-104,686 Reduced 44.68%
129,622 $1.91 Million
Q1 2022

May 16, 2022
BUY
$15.39 - $20.25 $2.07 Million - $2.72 Million
134,398 Added 134.52%
234,308 $4.53 Million
Q4 2021

Feb 14, 2022
SELL
$15.91 - $18.72 $237,584 - $279,545
-14,933 Reduced 13.0%
99,910 $1.72 Million
Q3 2021

Nov 15, 2021
BUY
$13.06 - $17.24 $800,486 - $1.06 Million
61,293 Added 114.46%
114,843 $1.92 Million
Q2 2021

Aug 16, 2021
SELL
$11.45 - $13.96 $261,529 - $318,860
-22,841 Reduced 29.9%
53,550 $718,000
Q1 2021

May 17, 2021
BUY
$11.06 - $12.87 $398,657 - $463,899
36,045 Added 89.34%
76,391 $913,000
Q4 2020

Feb 16, 2021
SELL
$9.33 - $12.48 $1.07 Million - $1.43 Million
-114,544 Reduced 73.95%
40,346 $500,000
Q3 2020

Nov 16, 2020
BUY
$10.33 - $14.49 $1.17 Million - $1.65 Million
113,553 Added 274.7%
154,890 $1.62 Million
Q2 2020

Aug 14, 2020
SELL
$11.49 - $15.26 $191,572 - $254,429
-16,673 Reduced 28.74%
41,337 $578,000
Q1 2020

May 15, 2020
BUY
$8.11 - $15.23 $470,461 - $883,492
58,010 New
58,010 $682,000
Q4 2019

Feb 14, 2020
SELL
$10.28 - $14.38 $317,590 - $444,255
-30,894 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$10.05 - $14.55 $329,368 - $476,847
-32,773 Reduced 51.48%
30,894 $326,000
Q2 2019

Aug 14, 2019
BUY
$13.1 - $14.95 $769,192 - $877,819
58,717 Added 1186.2%
63,667 $927,000
Q1 2019

May 15, 2019
SELL
$13.69 - $20.06 $1.43 Million - $2.09 Million
-104,179 Reduced 95.46%
4,950 $69,000
Q4 2018

Feb 14, 2019
BUY
$13.96 - $18.26 $1.35 Million - $1.76 Million
96,550 Added 767.55%
109,129 $1.9 Million
Q3 2018

Nov 14, 2018
SELL
$13.63 - $15.7 $615,394 - $708,855
-45,150 Reduced 78.21%
12,579 $192,000
Q2 2018

Aug 14, 2018
BUY
$13.44 - $17.59 $549,884 - $719,677
40,914 Added 243.32%
57,729 $797,000
Q1 2018

May 15, 2018
SELL
$13.8 - $16.99 $17,719 - $21,815
-1,284 Reduced 7.09%
16,815 $280,000
Q4 2017

Feb 14, 2018
SELL
$11.73 - $14.75 $187,539 - $235,823
-15,988 Reduced 46.9%
18,099 $257,000
Q3 2017

Nov 14, 2017
BUY
$12.06 - $14.12 $411,089 - $481,308
34,087
34,087 $481,000

Others Institutions Holding INVA

# of Institutions
229
Shares Held
79.2M
Call Options Held
37.6K
Put Options Held
300
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email